Krebs, Jeremy

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial

Corley, B. T., Carroll, R. W., Hall, R. M., Weatherall, M., Parry‐Strong, A., & Krebs, J. D. (2018) · Diabetic Medicine

Dietary Effects on HealthDiabetes Management and Research

Cited by 217

The impact of long chain n ‐3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype

Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O’Connell, M. A., & Jebb, S. A. (2007) · Diabetes Obesity and Metabolism

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 162

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Improvements in Glucose Metabolism and Insulin Sensitivity with a Low-Carbohydrate Diet in Obese Patients with Type 2 Diabetes

Krebs, J. D., Bell, D., Hall, R., Parry-Strong, A., Docherty, P. D., Clarke, K., & Chase, J. G. (2013) · Journal of the American College of Nutrition

Diet and metabolism studiesDietary Effects on Health

Cited by 65

The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: An open-label cross-over randomised controlled trial

Whitfield, P., Parry-Strong, A., Walsh, E., Weatherall, M., & Krebs, J. D. (2016) · European Journal of Nutrition

Natural Antidiabetic Agents StudiesBee Products Chemical Analysis

Cited by 51

Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition?

Scholtens, E. L., Krebs, J. D., Corley, B. T., & Hall, R. M. (2020) · Clinical Nutrition

Dietary Effects on HealthNutritional Studies and Diet

Cited by 41

Impact of a comprehensive digital health programme on HbA1c and weight after 12 months for people with diabetes and prediabetes: a randomised controlled trial.

McLeod, M., Stanley, J., Signal, V., Stairmand, J., Thompson, D., Henderson, K., Davies, C., Krebs, J., Dowell, A., Grainger, R., et al. (2020) · Diabetologia

Mobile Health and mHealth ApplicationsDiabetes Management and Education

Cited by 36

Weight-based carbohydrate treatment of hypoglycaemia in people with type 1 diabetes using insulin pump therapy: A randomized crossover clinical trial

McTavish, L., Corley, B., Weatherall, M., Wiltshire, E., & Krebs, J. D. (2018) · Diabetic Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 34

Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight‐based protocol compared with two fixed‐dose glucose regimens

Krebs, J. D., Weatherall, M., Corley, B., Wiltshire, E., & McTavish, L. (2018) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 7